Speaking Engagement: CEO Yosuke Ozawa Presented at Sysmex Online Seminar

On May 13, 2026, Yosuke Ozawa, CEO of Epistra Inc., presented at the online seminar “Emerging Technology Trends Shaping Next-Generation Research: From Basics to Non-Clinical and Regenerative Medicine,” organized by Sysmex Corporation. His talk was titled “Drug Development as a Series of Optimal Design Problems.”

Event Overview

Sysmex Online Seminar: “Emerging Technology Trends Shaping Next-Generation Research: From Basics to Non-Clinical and Regenerative Medicine”

• Organizer: Sysmex Corporation
• Date: Wednesday, May 13, 2026, 14:00–16:15
• Format: Online (Zoom)
• Registration: Free, pre-registration required
• Event page: https://gwfb.cdn.msgs.jp/wrmg/gwfb/SysmexOnlineSeminar_260513_guide.htm

The seminar was structured across five sessions spanning basic research, non-clinical studies, and regenerative medicine, covering a broad range of cutting-edge technologies in the life sciences and biotechnology fields. Topics included the latest developments in Sysmex Corporation’s CN™-700 fully automated coagulation analyzer, MASH therapeutic development by Cyfuse Biomedical K.K., and AI-based label-free cell sorting technology from ThinkCyte, Inc.

Presentation Content

Epistra presented in the second session, with a talk titled “Drug Development as a Series of Optimal Design Problems.”

Drug research and development involves numerous variables and complex constraints at every phase — from candidate compound selection and formulation design to clinical trial protocol development. The presentation reframed this structure as a series of optimization problems and introduced the potential of mathematical optimization in supporting decision-making across the life science and pharmaceutical fields, along with Epistra’s technical approach.